SHANNON WHITWELL: Open Payments
NPI 1437619277 · MARTINEZ, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 24 payments from 10 companies in 2025. Trend: 2023 $2,286 · 2024 $1,000 · 2025 $558
Food & beverage: $459Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $208 |
| Lilly USA, LLC | 4 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Novo Nordisk Inc | 2 | $33 |
| ABBVIE INC. | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| MILLICENT US INC | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $14 |
Products named: ZEPBOUND, Veozah, TRINTELLIX, Wegovy, QULIPTA, GEMTESA, FEMRING, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
